Cancer Research Institute logo

Cancer Research Institute

North America, New York, United States, New York

Description

CRI is the world's only nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers.

Investor Profile

Cancer Research Institute has made 5 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (40%)
  • Seed (40%)
  • Series B (20%)

Country Focus

  • United States (80%)
  • United Kingdom (20%)

Industry Focus

  • Biotechnology
  • Life Science
  • Health Care
  • Biopharma
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cancer Research Institute frequently co-invest with?

Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 2
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Camford Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Wing Venture Capital
North America, California, United States, Palo Alto
Co-Investments: 2
8VC
North America, California, United States, San Francisco
Co-Investments: 3
Artis Ventures (AV)
North America, California, United States, San Francisco
Co-Investments: 2
Pitango VC
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2
Intuitive Ventures
North America, California, United States, Sunnyvale
Co-Investments: 2
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 2
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 2

What are some of recent deals done by Cancer Research Institute?

OverT Bio

New York, New York, United States

OverT Bio operates as a biotech company that provide cell therapy for cancers.

BiotechnologyTherapeutics
SeedMay 6, 2024
Amount Raised: $16,000,000
Infinitopes

Oxford, Oxfordshire, United Kingdom

Infinitopes is developer of vaccines for the treatment of cancer.

Biotechnology
SeedApr 30, 2024
Amount Raised: $15,985,813
SURGE Therapeutics

Cambridge, Massachusetts, United States

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

BiotechnologyHealth CareLife Science
Series BJul 19, 2023
Amount Raised: $32,000,000
SURGE Therapeutics

Cambridge, Massachusetts, United States

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

BiotechnologyHealth CareLife Science
Series AOct 17, 2022
Amount Raised: $26,000,000
Cartography Biosciences

Foster City, California, United States

Cartography is shaping a world in which cancer immunotherapies are designed around and directed toward the safest, most effective targets.

BiopharmaBiotechnologyLife Science
Series AJul 19, 2022
Amount Raised: $57,000,000